Stenocare AS (OCSE:STENO) Common Stock : kr1.62 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Stenocare AS Common Stock?

Stenocare AS's quarterly common stock increased from Jun. 2024 (kr1.47 Mil) to Sep. 2024 (kr1.62 Mil) but then stayed the same from Sep. 2024 (kr1.62 Mil) to Dec. 2024 (kr1.62 Mil).

Stenocare AS's annual common stock increased from Dec. 2022 (kr0.93 Mil) to Dec. 2023 (kr1.47 Mil) and increased from Dec. 2023 (kr1.47 Mil) to Dec. 2024 (kr1.62 Mil).

Stenocare AS Common Stock Historical Data

The historical data trend for Stenocare AS's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stenocare AS Common Stock Chart

Stenocare AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Common Stock

Get a 7-Day Free Trial

0.93

1.47

1.62

Stenocare AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Common Stock	Get a 7-Day Free Trial															1.47	1.47	1.47	1.62	1.62

Stenocare AS Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Stenocare AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stenocare AS (OCSE:STENO) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Nyholmsvej 4, Randers NØ, DNK, 8930

Website

https://www.stenocare.com

Stenocare AS is a Danish company engaged in the cultivation and production of medical cannabis products through pharmacies and hospitals. The Company's business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The Company is a supplier of medical cannabis oil for patients in Denmerk, Sweden, UK, Australia and Norway. It has an indoor production facility for the cultivation and production of medical cannabis at Randers, Denmark.

Stenocare AS Headlines

No Headlines